Clincosm LogoSign in Get a demo

Intraocular Melanoma

Showing 26 - 33 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intraocular Melanoma, Melanoma (Skin) Trial in New York (pegylated interferon alfa, temozolomide)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 4, 2013

Intraocular Melanoma, Melanoma (Skin) Trial in Detroit (PEG-interferon alfa-2b, thalidomide)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 5, 2013

Intraocular Melanoma, Melanoma (Skin) Trial in New York (lomustine, temozolomide, thalidomide)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 17, 2013

Intraocular Melanoma, Melanoma (Skin) Trial in Baltimore (pyrazoloacridine)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dec 12, 2012

Intraocular Melanoma, Metastatic Cancer Trial in Worldwide (fotemustine, isolated perfusion)

Terminated
  • Intraocular Melanoma
  • Metastatic Cancer
  • Milan, Italy
  • +7 more
Sep 20, 2012

Intraocular Melanoma Trial in Brussels, Copenhagen (MART-1 antigen, NA17-A antigen, gp100 antigen)

Terminated
  • Intraocular Melanoma
  • MART-1 antigen
  • +3 more
  • Brussels, Belgium
  • +1 more
Sep 20, 2012

Melanoma (Skin), Intraocular Melanoma Trial in New York (Xenogeneic Tyrosinase DNA Vaccine, TriGrid Delivery System for

Completed
  • Melanoma (Skin)
  • Intraocular Melanoma
  • Xenogeneic Tyrosinase DNA Vaccine
  • TriGrid Delivery System for Intramuscular Electroporation
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 3, 2011

Bone Marrow and Blood Samples From Metastatic Choroid Melanoma

Completed
  • Intraocular Melanoma
  • gene expression analysis
  • +2 more
  • (no location specified)
May 12, 2011